Non-Viral Transfection Reagents Market is segmented By Non-Viral Transfection Reagents (Lipid-based ...
Market Size in USD Mn
CAGR8.5%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 8.5% |
Market Concentration | Medium |
Major Players | Thermo Fisher Scientific, MaxCyte, MilliporeSigma, Bio-Rad Laboratories, Altogen Biosystems and Among Others |
The non-viral transfection reagents market is estimated to be valued at USD 745.4 Mn in 2025 and is expected to reach USD 1319.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032.
The non-viral transfection reagents market is expected to witness a positive growth trend over the forecast period. The demand for non-viral transfection is higher due to various advantages over viral transfection such as reduced cytotoxicity, immunogenicity, and mutagenicity. Moreover, non-viral methods cause less damage to transfected cells. Advancements in transfection technologies and development of novel products are further expected to support the market growth.